Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum

Peritoneal fibrosis (PF) is characterized by progressive accumulation of extracellular matrix (ECM) components in the peritoneum under high glucose conditions. Rapamycin has previously been shown to inhibit ECM accumulation of peritoneal mesothelial cells (PMCs) and prevent PF. Here we explored the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Transl Res
Prif Awduron: Liu, Jing, Jiang, Chun-Ming, Feng, Yuan, Zhu, Wei, Jin, Bo, Xia, Yang-Yang, Zhang, Qing-Yan, Xu, Peng-Fei, Zhang, Miao
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: e-Century Publishing Corporation 2019
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456554/
https://ncbi.nlm.nih.gov/pubmed/30972175
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg